Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome

被引:22
作者
Alp, Esra [1 ]
Gormus, Uzay [1 ]
Guducu, Nilgun [2 ]
Bozkurt, Selen [3 ]
机构
[1] Istanbul Bilim Univ, Sch Med, Dept Biochem, Istanbul, Turkey
[2] Istanbul Bilim Univ, Sch Med, Dept Obstet & Gynecol, Istanbul, Turkey
[3] Akdeniz Univ, Dept Biostat, TR-07058 Antalya, Turkey
关键词
Body mass index; insulin; ovary; polycystic ovary syndrome; OBESITY; BRAIN;
D O I
10.3109/09513590.2015.1024219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nesfatin-1 is a novel hormon synthesized in hypothalamus and several other specific organs to regulate eating habits, appetite and is thought to be related to ovarian functions. In our study, we aimed to evaluate the nesfatin-1 levels with other metabolic parameters in polycystic ovary syndrome (PCOS), a condition that is known to be related to both ovarian functions and obesity. Study subjects were chosen from the women attended to the Obstetrics and Gynecology Department of Istanbul Bilim University, Avrupa Florence Nightingale Hospital. Thirty-five healthy control subjects and 55 PCOS patients were included. Blood samples were obtained on the 3rd day of the menstrual cycle. Luteinizing hormone (LH), follicle stimulating hormone (FSH), free testosterone (FT), dehydroepiandrosterone sulfate (DHEA-S), insulin, fasting blood glucose (FBG), high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG), sex hormone binding globulin (SHBG) levels were measured; homeostatic model assessment-insulin resistance (HOMA-IR) value was calculated. The nesfatin-1 levels were measured by competitive inhibition ELISA method. Due to our results, PCOS patients were having lower nesfatin-1 levels compared to the control group and this was not seemed to be related to body mass index (BMI) levels. This is an important result to be investigated in larger study groups and is related to other metabolic markers.
引用
收藏
页码:543 / 547
页数:5
相关论文
共 29 条
[1]   Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome [J].
Adamska, Agnieszka ;
Karczewska-Kupczewska, Monika ;
Nikolajuk, Agnieszka ;
Otziomek, Elzbieta ;
Gorska, Maria ;
Kowalska, Irina ;
Straczkowski, Marek .
ENDOCRINE JOURNAL, 2013, 60 (09) :1107-1113
[2]   Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome [J].
Ademoglu, Esra Nur ;
Gorar, Suheyla ;
Carlioglu, Ayse ;
Yazici, Havva ;
Dellal, Fatma Dilek ;
Berberoglu, Zehra ;
Akdeniz, Derya ;
Uysal, Sema ;
Karakurt, Feridun .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08) :715-719
[3]   Multi-functional peptide hormone NUCB2/nesfatin-1 [J].
Aydin, Suleyman .
ENDOCRINE, 2013, 44 (02) :312-325
[4]   Treatment options for polycystic ovary syndrome [J].
Badawy, Ahmed ;
Elnashar, Abubaker .
INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 :25-35
[5]   Polycystic Ovary Syndrome in the Pediatric Population [J].
Bremer, Andrew A. .
METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (05) :375-394
[6]   The adverse effects of obesity on conception and implantation [J].
Brewer, Christopher J. ;
Balen, Adam H. .
REPRODUCTION, 2010, 140 (03) :347-364
[7]   CORRELATION OF HYPERANDROGENISM WITH HYPERINSULINISM IN POLYCYSTIC OVARIAN DISEASE [J].
BURGHEN, GA ;
GIVENS, JR ;
KITABCHI, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) :113-116
[8]   Nesfatin-1 and other hormone alterations in polycystic ovary syndrome [J].
Deniz, Rulin ;
Gurates, Bilgin ;
Aydin, Suleyman ;
Celik, Husnu ;
Sahin, Ibrahim ;
Baykus, Yakup ;
Catak, Zekiye ;
Aksoy, Aziz ;
Citil, Cihan ;
Gungor, Sami .
ENDOCRINE, 2012, 42 (03) :694-699
[9]  
Fica Simona, 2008, J Med Life, V1, P415
[10]   Follicle dynamics and anovulation in polycystic ovary syndrome [J].
Franks, Stephen ;
Stark, Jaroslav ;
Hardy, Kate .
HUMAN REPRODUCTION UPDATE, 2008, 14 (04) :367-378